A Randomized Trial of Acute Normovolemic Hemodilution in Cardiac Surgery

医学 随机对照试验 心脏外科 麻醉 外科
作者
Fabrizio Monaco,Chong Lei,Matteo Aldo Bonizzoni,Sergey Efremov,Federica Morselli,Fabio Guarracino,Giuseppe Giardina,Cristina Arangino,Domenico Pontillo,Michelangelo Vitiello,Alessandro Belletti,Valentina Ajello,Margherita Licheri,Caetano Nigro Neto,Gaia Barucco,Nazar Bukamal,Carolina Faustini,Lorenzo Mantovani,Alessandro Oriani,Cristina Santonocito
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
被引量:1
标识
DOI:10.1056/nejmoa2504948
摘要

Patients undergoing cardiac surgery often receive red-cell transfusions, along with the associated risks and costs. Early intraoperative normovolemic hemodilution (i.e., acute normovolemic hemodilution [ANH]) is a blood-conservation technique that entails autologous blood collection before initiation of cardiopulmonary bypass and reinfusion of the collected blood after bypass weaning. More data are needed on whether ANH reduces the number of patients receiving allogeneic red-cell transfusion. In a multinational, single-blind trial, we randomly assigned adults from 32 centers and 11 countries who were undergoing cardiac surgery with cardiopulmonary bypass to receive ANH (withdrawal of ≥650 ml of whole blood with crystalloids replacement if needed) or usual care. The primary outcome was the transfusion of at least one unit of allogeneic red cells during the hospital stay. Secondary outcomes were death from any cause within 30 days after surgery or during the hospitalization for surgery, bleeding complications, ischemic complications, and acute kidney injury. A total of 2010 patients underwent randomization; 1010 were assigned to ANH and 1000 to usual care. Among patients with available data, 274 of 1005 (27.3%) in the ANH group and 291 of 997 (29.2%) in the usual-care group received at least one allogeneic red-cell transfusion (relative risk, 0.93; 95% confidence interval, 0.81 to 1.07; P = 0.34). Surgery for postoperative bleeding was performed in 38 of 1004 patients (3.8%) in the ANH group and 26 of 995 patients (2.6%) in the usual-care group. Death within 30 days or during hospitalization occurred in 14 of 1008 patients (1.4%) in the ANH group and 16 of 997 patients (1.6%) in the usual-care group. Safety outcomes were similar in the two groups. Among adults undergoing cardiac surgery, ANH did not reduce the number of patients receiving allogeneic red-cell transfusion. (Funded by the Italian Ministry of Health; ANH ClinicalTrials.gov number, NCT03913481.).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
清爽老九完成签到,获得积分10
1秒前
YY1023发布了新的文献求助10
1秒前
6秒前
阿芙乐尔完成签到 ,获得积分10
9秒前
舒心谷雪完成签到 ,获得积分10
9秒前
Iris完成签到 ,获得积分10
10秒前
SEM小菜鸡发布了新的文献求助10
10秒前
茹茹发布了新的文献求助10
10秒前
阿茉关注了科研通微信公众号
11秒前
nyg1234完成签到,获得积分10
14秒前
15秒前
Linda完成签到,获得积分10
16秒前
16秒前
无忧皮卡完成签到,获得积分10
19秒前
共享精神应助SEM小菜鸡采纳,获得10
19秒前
狂野萤发布了新的文献求助10
19秒前
20秒前
21秒前
22秒前
北越惊鸿发布了新的文献求助10
22秒前
隐形曼青应助无忧皮卡采纳,获得10
24秒前
24秒前
琪音_xy发布了新的文献求助10
25秒前
阿梅梅梅发布了新的文献求助10
28秒前
今后应助狂野萤采纳,获得10
28秒前
黑化小狗发布了新的文献求助10
29秒前
哆啦A梦完成签到,获得积分10
29秒前
30秒前
陶醉如柏完成签到,获得积分10
30秒前
狂野未来完成签到,获得积分10
31秒前
34秒前
兔子不爱吃胡萝卜完成签到 ,获得积分10
34秒前
36秒前
yyzhou应助欣慰问玉采纳,获得10
36秒前
科研通AI6应助欣慰问玉采纳,获得10
36秒前
37秒前
琪音_xy完成签到,获得积分10
38秒前
云卷云舒发布了新的文献求助10
39秒前
木木杨完成签到,获得积分10
39秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
F-35B V2.0 How to build Kitty Hawk's F-35B Version 2.0 Model 2000
中国兽药产业发展报告 1000
Biodegradable Embolic Microspheres Market Insights 888
Quantum reference frames : from quantum information to spacetime 888
The Netter Collection of Medical Illustrations: Digestive System, Volume 9, Part III - Liver, Biliary Tract, and Pancreas (3rd Edition) 600
Pediatric Injectable Drugs 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4448423
求助须知:如何正确求助?哪些是违规求助? 3917218
关于积分的说明 12159502
捐赠科研通 3566570
什么是DOI,文献DOI怎么找? 1958557
邀请新用户注册赠送积分活动 997986
科研通“疑难数据库(出版商)”最低求助积分说明 893157